United Asset Strategies’s Labcorp LH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-29,276
Closed -$7.9M 225
2021
Q4
$7.9M Buy
29,276
+614
+2% +$152K 0.94% 41
2021
Q3
$6.93M Buy
28,662
+916
+3% +$231K 0.89% 41
2021
Q2
$6.58M Sell
27,746
-2,960
-10% -$674K 0.88% 43
2021
Q1
$6.73M Buy
30,706
+855
+3% +$172K 0.98% 41
2020
Q4
$5.22M Buy
29,851
+1,447
+5% +$250K 0.82% 44
2020
Q3
$4.59M Buy
28,404
+938
+3% +$149K 0.84% 43
2020
Q2
$3.92M Buy
27,466
+1,378
+5% +$191K 0.77% 46
2020
Q1
$2.83M Buy
26,088
+1,077
+4% +$155K 0.7% 43
2019
Q4
$3.63M Buy
25,011
+1,562
+7% +$226K 0.71% 49
2019
Q3
$3.38M Buy
23,449
+1,100
+5% +$161K 0.74% 48
2019
Q2
$3.32M Buy
22,349
+512
+2% +$71.4K 0.76% 46
2019
Q1
$2.87M Buy
21,837
+844
+4% +$104K 0.67% 49
2018
Q4
$2.28M Sell
20,993
-7,135
-25% -$956K 0.62% 50
2018
Q3
$4.2M Buy
28,128
+1,094
+4% +$166K 0.99% 31
2018
Q2
$4.17M Buy
27,034
+1,321
+5% +$199K 1.1% 29
2018
Q1
$3.57M Buy
25,713
+128
+0.5% +$18.8K 1.05% 34
2017
Q4
$3.51M Buy
+25,585
New +$3.38M 0.94% 32

Other funds holding LH

United Asset Strategies's LH Position: Q1 2022 in Review

United Asset Strategies sold out of Labcorp (LH) in Q1 2022, closing a stake of 29,276 shares — an estimated $7.9M sold.

United Asset Strategies first reported a position in LH in Q4 2017 and held it in 17 quarters. The position peaked at $7.9M in Q4 2021. 1,034 funds tracked by Wall St. Rank hold LH as of Q1 2022.

  • United Asset Strategies reported no remaining Labcorp position as of Q1 2022 after selling out during the quarter.
  • United Asset Strategies sold 29,276 Labcorp shares in Q1 2022, an estimated $7.9M.
  • United Asset Strategies first reported a position in Labcorp in Q4 2017 and held it in 17 quarters.
  • United Asset Strategies's Labcorp position peaked at $7.9M in Q4 2021.
  • 1,034 funds tracked by Wall St. Rank held Labcorp as of Q1 2022.

Based on United Asset Strategies's 13F filing for Q1 2022, filed 29 Apr 2022.